Jennifer B. Damico - 13 Aug 2021 Form 4 Insider Report for PFIZER INC (PFE)

Role: SVP & Controller
Signature: Susan E. Grant, by power of atty., for Jennifer B. Damico
Issuer symbol: PFE
Transactions as of: 13 Aug 2021
Net transactions value: -$79,014
Form type: 4
Filing time: 16 Aug 2021, 20:12:45 UTC
Previous filing: 02 Aug 2021
Next filing: 01 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Sale	$48.29	-1	-0.01%	$48.29	11,429	13 Aug 2021	Direct
transaction	PFE	Common Stock	Sale	$80,178	-1,660	-15%	$48.30	9,769	13 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Phantom Stock Units SSP	Award	$1,212	+25	+0.17%	$48.48	14,818	13 Aug 2021	Common Stock	25		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each unit represents one phantom share of common stock.
F2	These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.